The thrombomodulin-protein C system is essential for the maintenance of pregnancy

Nature Medicine

Volumn 9, Issue 3, 2003, Pages 331-337

  Isermann, Berend ^a   Sood, Rashmi ^a   Pawlinski, Rafal ^b   Zogg, Mark ^a   Kalloway, Shawn ^a   Degen, Jay L ^c   Mackman, Nigel ^b   Weiler, Hartmut ^a,d  

^a BLOOD RESEARCH INSTITUTE   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR; FIBRIN; FIBRINOGEN; PROTEIN C; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE ACTIVATED RECEPTOR 4; THROMBIN; THROMBOMODULIN; THROMBOPLASTIN; WARFARIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL INFECTION; BLOOD CLOTTING; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; FIBRINOLYSIS; GROWTH INHIBITION; HOST RESISTANCE; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; PLACENTA; PREGNANCY; PRIORITY JOURNAL; TROPHOBLAST;

ABORTION, SPONTANEOUS; ANIMALS; BLOOD COAGULATION; CELL DIVISION; EMBRYO; EMBRYO LOSS; FEMALE; FIBRIN; FIBRINOGEN; IN SITU HYBRIDIZATION; IN SITU NICK-END LABELING; MALE; MICE; MICE, INBRED C57BL; PLACENTA; PLASMIN; PREGNANCY; PREGNANCY MAINTENANCE; PROTEIN C; RECEPTOR, PAR-2; RECEPTORS, THROMBIN; THROMBIN; THROMBOMODULIN; THROMBOPLASTIN; TROPHOBLASTS;

ANIMALIA; BACTERIA (MICROORGANISMS); RICKETTSIA SP. PAR;

EID: 0037349926     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm825     Document Type: Article

References (45)

1. Esmon, C.T. Regulation of blood coagulation. Biochim. Biophys. Acta 1477, 349-360(2000).
2. Taylor, F.B., Peer, G.T., Lockhart, M.S., Ferrell, G. & Esmon, C.T. Endothelial cell protein C receptor plays an important role in protein C activation in vivo. Blood 97, 1685-1688 (2001).
3. Healy, A.M., Rayburn, H.B., Rosenberg, R.D. & Weiler, H. Absence of the blood-clotting regulator thrombomodulin causes embryonic lethality in mice before development of a functional cardiovascular system. Proc. Natl. Acad. Sci. USA 92, 850-854 (1995).
4. Weiler-Guettler, H., Aird, W.C., Rayburn, H., Husain, M. & Rosenberg, R.D. Developmentally regulated gene expression of thrombomodulin in postimplantation mouse embryos. Development 122, 2271-2281 (1996).
5. Weiler-Guettler, H., Aird, W.C., Husain, M., Rayburn, H. & Rosenberg, R.D. Targeting of transgene expression to the vascular endothelium of mice by homologous recombination at the thrombomodulin locus. Circ. Res. 78, 180-187 (1996).
6. Isermann, B., Hendrickson, S.B., Hutley, K., Wing, M. & Weiler, H. Tissue-restricted expression of thrombomodulin in the placenta rescues thrombomodulin-deficient mice from early lethality and reveals a secondary developmental block. Development 128, 827-838 (2001).
7. Weiler-Guettler, H. et al. A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state. J. Clin. Invest. 101, 1983-1991 (1998).
8. Zhang, Y. et al. Thrombomodulin modulates growth of tumor cells independent of its anticoagulant activity. J. Clin. Invest. 101, 1301-1309 (1998).
9. Wang, W., Nagashima, M., Schneider, M., Morser, J. & Nesheim, M. Elements of the primary structure of thrombomodulin required for efficient thrombin-activable fibrinolysis inhibitor activation. J. Biol. Chem. 275, 22942-22947 (2000).
10. Nesheim, M. et al. Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis. Thromb. Haemost. 78, 386-391 (1997).
11. Weitz, J.I., Hudoba, M., Massel, D., Maraganore, J. & Hirsh, I. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. J. Clin. Invest. 86, 385-391 (1990).
12. Zivelin, A., Rao, L.V. & Rapaport, S.I. Mechanism of the anticoagulant effect of warfarin as evaluated in rabbits by selective depression of individual procoagulant vitamin K- dependent clotting factors. J. Clin. Invest. 92, 2131-2140 (1993).
13. Carmeliet, P. et al. Role of tissue factor in embryonic blood vessel development. Nature 383, 73-75 (1996).
14. Bugge, T.H. et al. Fatal embryonic bleeding events in mice lacking tissue factor, the cell- associated initiator of blood coagulation. Proc. Natl. Acad. Sci. USA 93, 6258-6263 (1996).
15. Toomey, J.R., Kratzer, K.E., Lasky, N.M., Stanton, J.J. & Broze, G.J. Targeted disruption of the murine tissue factor gene results in embryonic lethality. Blood 88, 1583-1587 (1996).
16. Parry, G.C., Erlich, J.H., Carmeliet, P., Luther, T. & Mackman, N. Low levels of tissue factor are compatible with development and hemostasis in mice. J. Clin. Invest. 101, 560-569 (1998).
17. Erlich, J. et al. Tissue factor is required for uterine hemostasis and maintenance of the placental labyrinth during gestation. Proc. Natl. Acad. Sci. USA 96, 8138-8143 (1999).
18. Suh, T.T. et al. Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice. Genes Dev. 9, 2020-2033 (1995).
19. Tanaka, S., Kunath, T., Hadjantonakis, A.K., Nagy, A. & Rossant, J. Promotion of trophoblast stem cell proliferation by FGF4. Science 282, 2072-2075 (1998).
20. Ratts, V.S. et al. Expression of BCL-2, BAX and BAK in the trophoblast layer of the term human placenta: a unique model of apoptosis within a syncytium. Placenta 21, 361-366 (2000).
21. Toki, T. et al. Inverse relationship between apoptosis and Bcl-2 expression in syncytiotrophoblast and fibrin-type fibrinoid in early gestation. Mol. Hum. Reprod. 5, 246-251 (1999).
22. Tsumagari, T. & Tanaka, K. Effects of fibrinogen degradation products on glomerular mesangial cells in culture. Kidney Int. 26, 712-718 (1984).
23. Frisch, S.M. & Screaton, R.A. Anoikis mechanisms. Curr. Opin. Cell Biol. 13, 555-562 (2001).
24. Buckley, C.D. et al. RGD peptides induce apoptosis by direct caspase-3 activation. Nature 397, 534-539 (1999).
25. Teesalu, T., Blasi, F. & Talarico, D. Expression and function of the urokinase type plasminogen activator during mouse hemochorial placental development. Dev. Dyn. 213, 27-38 (1998).
26. Strickland, S. & Richards, W.G. Invasion of the trophoblasts. Cell 71, 355-357 (1992).
27. Hu, Z.Y. et al. Expression of tissue type and urokinase type plasminogen activators as well as plasminogen activator inhibitor type-1 and type-2 in human and rhesus monkey placenta. J. Anat. 194, 183-195 (1999).
28. Riewaid, M., Petrovan, R.I., Donner, A., Mueller, B.M. & Ruf, W. Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science 296, 1880-1882 (2002).
29. Connolly, A.J., Ishihara, H., Kahn, M.L., Farese, R.V. & Coughlin, S.R. Role of the thrombin receptor in development and evidence for a second receptor. Nature 381, 516-519 (1996).
30. Gu, J.M. et al. Disruption of the endothelial cell protein C receptor gene in mice causes placental thrombosis and early embryonic lethality. J. Biol. Chem. 277, 43335-43343 (2002).
31. Crawley, I.T., Gu, J.M., Ferrell, G. & Esmon, C.T. Distribution of endothelial cell protein C/activated protein C receptor (EPCR) during mouse embryo development. Thromb. Haemost. 88, 259-266 (2002).
32. Coughlin, S.R. Thrombin signalling and protease-activated receptors. Nature 407, 258-264 (2000).
33. Cross, I.C., Werb, Z. & Fisher, S.J. Implantation and the placenta: key pieces of the development puzzle. Science 266, 1508-1518 (1994).
34. Fazel, A. et al. increase in expression and activity of thrombomodulin in term human syncytiotrophoblast microvilli. Placenta 19, 261-268 (1998).
35. Even-Ram, S. et al. Thrombin receptor overexpression in malignant and physiological invasion processes. Nat. Med. 4, 909-914 (1998).
36. Preston, F.E. et al. Increased fetal loss in women with heritable thrombophilia. lancet 348, 913-916 (1996).
37. Greet, I.A. Thrombosis in pregnancy: maternal and fetal issues. lancet 353, 1258-1265 (1999).
38. Kupferminc, M.J. et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N. Engl. J. Med. 340, 9-13 (1999).
39. Brenner, B. et al. Thrombophilic polymorphisms are common in women with fetal loss without apparent cause. Thromb. Haemost. 82, 6-9 (1999).
40. Blumenfeld, Z. & Brenner, B. Thrombophilia-associated pregnancy wastage. Fertil. Steril. 72, 765-774 (1999).
41. Out, H.J., Kooijman, C.D., Bruinse, H.W. & Derksen, R.H. Histopathological findings in placentae from patients with intra-uterine fetal death and anti-phospholipid antibodies. Eur. J. Obstet. Gynecol. Reprod. Biol. 41, 179-186 (1991).
42. Isermann, B. et al. Endothelium-specific loss of murine thrombomodulin disrupts the protein C anticoagulant pathway and causes juvenile-onset thrombosis. J. Clin. Invest. 108, 537-546 (2001).
43. Gogjian, M.A., Barry, K.J. & Stein, B.M. Measurement of fibrinolytic activity after ε-aminocaproic acid administration in rats (Rottus norvegicus). Lab Anim. Sci. 31, 710-711 (1981).
44. Braissant, O. & Wahli, W. A simplified in situ hybridization protocol using non-radioactively labeled probes to detect abundant and rare mRNAs on tissue sections. Biochemica 3, 10-16 (1998).
45. Rappolee, D.A., Basilico, C., Patel, Y. & Werb, Z. Expression and function of FGF-4 in peri-implantation development in mouse embryos. Development 120, 2259-2269 (1994).